Related Experiment Video
Updated: Feb 13, 2026
07:13
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
991
Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy
Rafal Pawlinski1, Michael Tencati, Craig R Hampton
1The Scripps Research Institute, Department of Immunology, 10550 N Torrey Pines Rd, La Jolla, CA 92037, USA.
Circulation
|October 31, 2007
Summary
Protease-activated receptor-1 (PAR-1) deficiency improves cardiac function after heart injury by reducing left ventricle dilation. However, PAR-1 deficiency did not affect infarct size, while its overexpression induced eccentric hypertrophy.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Thrombosis Research
Background:
- Protease-activated receptor-1 (PAR-1) is a receptor for thrombin, expressed in cardiac cells like cardiomyocytes and fibroblasts.
- PAR-1 signaling is implicated in cardiomyocyte hypertrophy and fibroblast proliferation.
- Tissue factor (TF) and thrombin are known contributors to cardiac ischemia-reperfusion (I/R) injury.
Purpose of the Study:
- To investigate the role of PAR-1 in cardiac infarction, remodeling, and hypertrophy following I/R injury.
- To analyze the effects of cardiomyocyte-specific PAR-1 overexpression on cardiac function and structure.
Main Methods:
- Utilized PAR-1 deficient (PAR-1-/-) and wild-type mice subjected to cardiac I/R injury.
- Investigated cardiac remodeling and function using echocardiography and histological analysis.
- Examined the impact of cardiomyocyte-specific PAR-1 overexpression and TF gene deletion.
Main Results:
- PAR-1 deficiency attenuated left ventricular dilation and improved cardiac function 2 weeks post-I/R injury.
- PAR-1 deficiency did not alter infarct size but increased ERK1/2 activation in injured areas.
- Cardiomyocyte-specific PAR-1 overexpression led to eccentric hypertrophy and dilated cardiomyopathy, which was reduced by deleting the TF gene in cardiomyocytes.
Conclusions:
- PAR-1 plays a significant role in cardiac remodeling and hypertrophy post-myocardial infarction.
- Overexpression of PAR-1 in cardiomyocytes induces eccentric hypertrophy, suggesting a mechanism for dilated cardiomyopathy.
- Targeting PAR-1 may offer a novel therapeutic strategy for reducing cardiac hypertrophy and heart failure after myocardial infarction.
Related Concept Videos
01:40Bone Remodeling
40.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.5K
02:54Nucleosome Remodeling
11.3K
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
11.3K
01:23Binet's Contribution to Measures of Intelligence
1.8K
Alfred Binet, along with his student Théophile Simon, was tasked by the French Ministry of Education in 1904 to create a method for identifying students who struggled to learn through conventional classroom instruction. This initiative aimed to address overcrowding by placing such students in specialized schools. Binet and Simon developed an intelligence test comprising 30 tasks, ranging from simple commands, like touching one's nose or ear, to more complex tasks, such as drawing...
1.8K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
649
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
649
01:31Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
01:23Wechsler's Contribution to Measures of Intelligence
2.1K
David Wechsler, a psychologist who worked with World War I veterans, developed a significant IQ test in 1939 called the Wechsler-Bellevue Intelligence Scale. This test was innovative because it combined several subtests that measured both verbal and nonverbal skills, reflecting Wechsler's belief that intelligence is a global capacity involving purposeful action, rational thinking, and effective interaction with the environment. This test later evolved into the Wechsler Adult Intelligence...
2.1K